Patent details

EP2077822 Title: OXCARBAZEPINE-CONTAINING ORAL FORMULATION AND A PROCESS TO OBTAIN THE SAME

Basic Information

Publication number:
EP2077822
PCT Application Number:
BR2007000261
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP078157039
PCT Publication Number:
WO2008037044
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
OXCARBAZEPINE-CONTAINING ORAL FORMULATION AND A PROCESS TO OBTAIN THE SAME
French Title of Invention:
FORMULATION ORALE CONTENANT OXCARBAZÉPINE ET SON PROCÉDÉ DE PRODUCTION
German Title of Invention:
OXCARBAZEPIN ENTHALTENDE ORALE FORMULIERUNG UND VERFAHREN ZU IHRER GEWINNUNG
SPC Number:

Dates

Filing date:
27/09/2007
Grant date:
25/04/2018
EP Publication Date:
15/07/2009
PCT Publication Date:
03/04/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/04/2018
EP B1 Publication Date:
25/04/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
27/09/2018
Expiration date:
27/09/2027
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/04/2018
 
 

Name:
Medley S.A. Indústria Farmacêutica
Address:
R. Macedo Costa, 55, Jd. Santa Genebra, 13080-180 Campinas - SP, Brazil (BR)

Inventor

Name:
NEGRÃO, Alexandre Funari
Address:
Brazil (BR)

Priority

Priority Number:
PI0604387
Priority Date:
27/09/2006
Priority Country:
Brazil (BR)

Classification

IPC classification:
A61K 9/14; A61K 31/16; A61K 31/165; A61K 31/55;

Publication

European Patent Bulletin

Issue number:
201817
Publication date:
25/04/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/01/2019 Outgoing Correspondence 1